The influence of chitosan on cyclodextrin complexing and solubilizing abilities towards drugs

  • Paola Mura
  • Giovanna Corti
  • Francesca Maestrelli
  • Marzia Cirri
Original Article
First Online:
Received:
Accepted:

Abstract

The present work was performed to investigate the effect of chitosan, a well known hydrophilic polymer with both enhancer and solubilizing properties, on the solubilizing and complexing abilities of cyclodextrins towards drugs. With this aim, phase-solubility studies were carried out with a series of model drugs, both of acid and basic nature and with different water-solubility and lipophilicity values, in the presence of chitosan and cyclodextrin (ß- or hydroxypropyl-ß-cyclodextrin), both separately (binary systems) and in combination (ternary systems). Unexpectedly, differently from the favorable effect reported in literature for various hydrophilic polymers, the addition of chitosan to the cyclodextrin complexation medium caused a decrease in the cyclodextrin complexing power towards all the examined drugs, independent from their very different physicochemical properties. On the contrary, the influence of the polymer on the cyclodextrin solubilizing efficiency was found to be dependent on the type of drug and both positive, or negative or non-significant effects were observed. The overall results are explained in terms of a common basic mechanism due to the presence of chitosan–cyclodextrin interactions, which hindered the drug–cyclodextrin complex formation, thus causing the binding constant reduction; the simultaneous presence of drug–chitosan and/or chitosan–(drug–cyclodextrin complex) interactions, different from drug to drug, were considered responsible for the distinct (and sometimes opposite) effects observed in the drug solubilizing efficiency of ternary systems.

Keywords

Chitosan Cyclodextrins Complexing and solubilizing abilities Phase-solubility studies Stability constants of complexes 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgment

Financial support from MIUR is gratefully acknowledged

References

  1. 1.
    Uekama, K., Hirayama, F., Irie, T.: Cyclodextrin drug carrier systems. Chem. Rev. 98, 2045–2076 (1998)CrossRefGoogle Scholar
  2. 2.
    Duchêne, D.: Cyclodextrins and their Industrials Uses. Ed. De Santé, Paris (1987)Google Scholar
  3. 3.
    Szejtli, J.: Cyclodextrin Technology, Kluwer Academic Publishers, Dordrecht (1988)Google Scholar
  4. 4.
    Loftsson, T., Brewster, M.: Pharmaceutical application of cyclodextrins – I: drug solubilization and stabilization. J. Pharm. Sci. 85, 1017–1025 (1996)CrossRefGoogle Scholar
  5. 5.
    Loftsson, T., Fridriksdóttir, H., Sigurdardóttir, A., Ueda, H.: The effect of water-soluble polymers on drug cyclodextrin complexation. Int. J. Pharm. 110, 169–177 (1994)CrossRefGoogle Scholar
  6. 6.
    Loftsson, T. Fridriksdóttir, H., Sigurdardóttir, A.M.: The effect of polymers on cyclodextrin complexation. In: Osa, T. (ed.) Proceedings of the 7th Intern. Symp. Cyclodextrins, pp 218–221. Academic Societies Japan, Tokyo (1994)Google Scholar
  7. 7.
    Loftsson, T., Gudmundsdóttir, T.K., Fridriksdóttir, F.: The influence of water-soluble polymers and pH on hydroxypropyl-ß-cyclodextrin complexation of drugs. Drug Dev. Ind. Pharm. 22, 401–405 (1996)CrossRefGoogle Scholar
  8. 8.
    Mura, P., Faucci, M.T., Bettinetti, G.P.: The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-ß-cyclodextrin. Eur. J. Pharm. Sci.: 13, 187–194 (2001)CrossRefGoogle Scholar
  9. 9.
    Faucci, M.T., Mura, P.: Effect of water-soluble polymers on naproxen complexation with natural and chemically-modified-ß-cyclodextrins. Drug Dev. Ind. Pharm. 27, 311–319 (2001)Google Scholar
  10. 10.
    Illum, L.: Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 15, 1326–1331 (1998)CrossRefGoogle Scholar
  11. 11.
    Felt, O., Buri, P., Gurny, R.: Chitosan: a unique polysaccharide for drug delivery, Drug Dev. Ind. Pharm. 24, 979–993 (1998)CrossRefGoogle Scholar
  12. 12.
    Paul, W., Sharma, C.P.: Chitosan, a drug carrier for the 21st century, S.T.P. Pharma Sci. 10, 5–22 (2000)Google Scholar
  13. 13.
    Shiraishi, S., Arahira, M., Imai, T., Otagiri, M.: Enhancement of dissolution rates of several drugs by low molecular chitosan and alginate. Chem. Pharm. Bull. 38, 185–187 (1990)Google Scholar
  14. 14.
    Portero, A., Remuñan-Lopez, C., Vila-Jato, J.L.: Effect of chitosan and chitosan glutamate enhancing the dissolution properties of the poorly water soluble drug nifedipine. Int. J. Pharm. 175, 75–84 (1998)CrossRefGoogle Scholar
  15. 15.
    Mura, P., Zerrouk, N., Mennini, N., Maestrelli, F., Chemtob, C.: Development and characterization of naproxen-chitosan solid systems with improved drug dissolution properties. Eur. J. Pharm. Sci. 19, 67–75 (2003)CrossRefGoogle Scholar
  16. 16.
    Zerrouk, N., Mennini, N., Maestrelli, F., Chemtob, C., Mura, P.: Comparison of the effect of chitosan and polyvynilpyrrolidone on dissolution properties and analgesic effect of naproxen. Eur. J. Pharm. Biopharm. 57, 93–99 (2004)CrossRefGoogle Scholar
  17. 17.
    Zerrouk, N., Corti, G., Ancillotti, S., Maestrelli, F., Cirri, M., Mura, P.: Influence of cyclodextrins and chitosan, separately or in combination, on glyburide solubility and permeability. Eur. J. Pharm. Biopharm. 62, 241–246 (2006)CrossRefGoogle Scholar
  18. 18.
    Maestrelli, F., García-Fuentes, M., Mura, P., Alonso, M.J.: A new drug nanocarrier consisting of chitosan and hydroxypropylcyclodextrin. Eur. J. Pharm. Biopharm. 63, 79–86 (2006)CrossRefGoogle Scholar
  19. 19.
    Higuchi, T., Connors, K.A.: Phase-solubility techniques. Adv. Anal. Chem. Instr. 4, 117–212 (1965)Google Scholar
  20. 20.
    Fujita, T., Iwasa, I., Hansch, C.: A new substituent constant P derived from partition coefficient. J. Am. Chem. Soc. 86, 5175–5180 (1964)CrossRefGoogle Scholar
  21. 21.
    Guttman, D., Higuchi, T.: Possible complex formation between macromolecules and certain pharmaceuticals. X: The interaction of some phenolic compounds with polyethylene glycols, polypropylene glycols, and polyvinylpyrrolidone. J. Am. Pharm. Assoc. Sci. Ed. 45, 659–664 (1956)CrossRefGoogle Scholar
  22. 22.
    Bettinetti, G.P., Mura, P., Liguori, A., Bramanti, G., Giordano, F.: Solubilization and interaction of naproxen with polyvinyl-pyrrolidone in aqueous solution and in the solid state. Farmaco 43, 331–343 (1988)Google Scholar
  23. 23.
    Acartürk, F., Kislal, O., Celebi, N.: The effect of some natural polymers on the solubility and dissolution characteristic of nifedipine. Int. J. Pharm. 85, 1–6 (1992)CrossRefGoogle Scholar
  24. 24.
    Loftsson, T., Fridriksdóttir, F., Gudmundsdóttir T.K.: The effect of water-soluble polymers on aqueous solubility of drugs. Int. J. Pharm. 127, 293–296 (1996)CrossRefGoogle Scholar
  25. 25.
    Mura, P., Manderioli, A., Bramanti, G., Ceccarelli, L.: The properties of solid dispersions of naproxen in various polyethylene glycols. Drug Dev. Ind. Pharm. 22, 909–916 (1996)Google Scholar
  26. 26.
    Rácz, I.: Drug Formulation, pp. 212–242. John Wiley and Sons, Budapest (1989)Google Scholar
  27. 27.
    Bettinetti, G.P., Melani, F., Mura, P., Monnanni, M., Giordano, F.: Carbon-13 NMR study of naproxen interaction with cyclodextrins in solution. J. Pharm. Sci. 80, 1162–1170 (1991)CrossRefGoogle Scholar
  28. 28.
    Salvadori, P., Uccello-Barretta, G., Balzano, F., Bertucci, C., Chiavacci, C.: NMR investigation of (+) and (−) flurbiprofen with beta-cyclodextrin. Chirality 8, 423–429 (1996)CrossRefGoogle Scholar
  29. 29.
    Mura, P., Bettinetti, G.P., Manderioli, A., Faucci, M.T., Bramanti, G., Sorrenti, M.: Interactions of ketoprofen and ibuprofen with ß-cyclodextrins in solution and in the solid state. Int. J. Pharm. 166, 189–203 (1998)CrossRefGoogle Scholar
  30. 30.
    Faucci, M.T., Melani, F., Mura, P.: 1H-NMR and molecular modelling techniques for the investigation of the inclusion complex of econazole with α-cyclodextrin in the presence of malic acid. J. Pharm. Biomed. Anal. 23, 25–31 (2000)CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2007

Authors and Affiliations

  • Paola Mura
    • 1
  • Giovanna Corti
    • 1
  • Francesca Maestrelli
    • 1
  • Marzia Cirri
    • 1
  1. 1.Department of Pharmaceutical SciencesUniversity of FlorenceSesto FiorentinoItaly

Personalised recommendations